Roberto B Salgado, Ph.D.
Affiliations: |
Area:
relativity, computation, pedagogyGoogle:
"Roberto Salgado"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Rafael Sorkin | grad student | 2008 | Syracuse | |
| (Toward a quantum dynamics for causal sets) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sharma P, Stecklein SR, Yoder R, et al. (2023) Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial. Jama Oncology |
| Rediti M, Fernandez-Martinez A, Venet D, et al. (2023) Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials. Nature Communications. 14: 7053 |
| Thagaard J, Broeckx G, Page DB, et al. (2023) Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group. The Journal of Pathology |
| Machiels M, Oulkadi R, Tramm T, et al. (2023) Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers. Breast (Edinburgh, Scotland). 71: 13-21 |
| Bergin ART, Salgado R, Loi S. (2023) Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic Status. Cancer Immunology Research. 11: 705-706 |
| Bergin ART, Salgado R, Loi S. (2023) Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic Status. Cancer Immunology Research. 11: 705-706 |
| Loi S, Salgado R, Schmid P, et al. (2023) Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis. Jco Precision Oncology. 7: e2200317 |
| Voorwerk L, Isaeva OI, Horlings HM, et al. (2023) PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial. Nature Cancer. 4: 535-549 |
| Jimeno R, Mouron S, Salgado R, et al. (2022) Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico |
| Mercan C, Balkenhol M, Salgado R, et al. (2022) Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer. Npj Breast Cancer. 8: 120 |